![148049-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/148049-Thumbnail%20Image.png?versionId=IiXacniHLjEqMgehpgJIeXJTIIX71pJL&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T154427Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=7aad06b2cd69e339a259411890c1132f821f566c1b986bb66672ddbbb1390a8d&itok=SgAk0-rt)
Cancer rates vary between people, between cultures, and between tissue types, driven by clinically relevant distinctions in the risk factors that lead to different cancer types. Despite the importance of cancer location in human health, little is known about tissue-specific cancers in non-human animals. We can gain significant insight into how evolutionary history has shaped mechanisms of cancer suppression by examining how life history traits impact cancer susceptibility across species. Here, we perform multi-level analysis to test how species-level life history strategies are associated with differences in neoplasia prevalence, and apply this to mammary neoplasia within mammals. We propose that the same patterns of cancer prevalence that have been reported across species will be maintained at the tissue-specific level. We used a combination of factor analysis and phylogenetic regression on 13 life history traits across 90 mammalian species to determine the correlation between a life history trait and how it relates to mammary neoplasia prevalence. The factor analysis presented ways to calculate quantifiable underlying factors that contribute to covariance of entangled life history variables. A greater risk of mammary neoplasia was found to be correlated most significantly with shorter gestation length. With this analysis, a framework is provided for how different life history modalities can influence cancer vulnerability. Additionally, statistical methods developed for this project present a framework for future comparative oncology studies and have the potential for many diverse applications.
![149856-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/149856-Thumbnail%20Image.png?versionId=WtU2R4ux2OmJmu7zhU56SKCqweNUe8b3&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T153810Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=38e546c43a2d6b889c51604533e8cdd9ff51e00aa7bae2856cf2c95580cc6d8a&itok=1Hec-1pA)
![151750-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151750-Thumbnail%20Image.png?versionId=PJgeV_ob7v3aqUhP6uirki0BT_YXX5Yd&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240606/us-west-2/s3/aws4_request&X-Amz-Date=20240606T084404Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=1cc506ecfaf07d54371582bc37685bea5e2efd8932173c28efed19fa925a174e&itok=SHUpCIKx)
![152144-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/152144-Thumbnail%20Image.png?versionId=2xTN57qGXeiGpfHrb4VUAW_sWiG_vPNU&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240605/us-west-2/s3/aws4_request&X-Amz-Date=20240605T200206Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=28d666863354dfccbeb54354b35ab44f093cfae182ac2a9a62f32ff16501dbe8&itok=5TzUPmxt)
![151493-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151493-Thumbnail%20Image.png?versionId=EeaxH0TOuWHuJ.MEZYTw6cqou2oNXagC&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240603/us-west-2/s3/aws4_request&X-Amz-Date=20240603T124717Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=a7c2b9d49f92fedb1daf58e024a3da4b6ba624f4b998c3ae320307d07a7a08d4&itok=4bP9wY0D)
![152032-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/152032-Thumbnail%20Image.png?versionId=fvgWXUkuFuMCDGAayCUVg7pNIYTBQ5zl&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T020436Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=932416850d6f71bd0e955689f9f08b80ab7b0d79d12290d52135fec7a3db3c34&itok=YZjwRv47)
![150493-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/150493-Thumbnail%20Image.png?versionId=hkvqwGweZA4bKXslEiaLUI4.Df3w6mLa&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240603/us-west-2/s3/aws4_request&X-Amz-Date=20240603T121325Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=79c6c769becaeb72e04eeb0ba13bb84a1f91fa15b8f4ca7bdf34554d8a629c5e&itok=OFF_szCF)
![151229-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151229-Thumbnail%20Image.png?versionId=8UzPssXyrsIjM.8NWoHuBxamLElebgGA&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240618/us-west-2/s3/aws4_request&X-Amz-Date=20240618T010452Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=d5315f863705734a4e44ce32116e180fef81b3c7f8f2082e06c279379194a903&itok=XpZjsLF-)
![148322-Thumbnail Image.png](/s3/files/styles/width_400/public/2021-07/148322-Thumbnail%20Image.png?itok=QWmIoEsJ)
The field of biomedical research relies on the knowledge of binding interactions between various proteins of interest to create novel molecular targets for therapeutic purposes. While many of these interactions remain a mystery, knowledge of these properties and interactions could have significant medical applications in terms of understanding cell signaling and immunological defenses. Furthermore, there is evidence that machine learning and peptide microarrays can be used to make reliable predictions of where proteins could interact with each other without the definitive knowledge of the interactions. In this case, a neural network was used to predict the unknown binding interactions of TNFR2 onto LT-ɑ and TRAF2, and PD-L1 onto CD80, based off of the binding data from a sampling of protein-peptide interactions on a microarray. The accuracy and reliability of these predictions would rely on future research to confirm the interactions of these proteins, but the knowledge from these methods and predictions could have a future impact with regards to rational and structure-based drug design.
![136566-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136566-Thumbnail%20Image.png?versionId=A2qiFM4K9c4RYxWcCwX439uUwfMNbrdp&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T153811Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f4ffc51b3f5482ba509d938a03e58a835d31d38071f6a870ddb1d850ed713fe9&itok=9uKmDthY)